518 related articles for article (PubMed ID: 30385238)
1. Antibiotic consumption versus the prevalence of carbapenem-resistant Gram-negative bacteria at a tertiary hospital in China from 2011 to 2017.
Zhang D; Hu S; Sun J; Zhang L; Dong H; Feng W; Lei J; Dong Y
J Infect Public Health; 2019; 12(2):195-199. PubMed ID: 30385238
[TBL] [Abstract][Full Text] [Related]
2. Association between antibiotic consumption and the rate of carbapenem-resistant Gram-negative bacteria from China based on 153 tertiary hospitals data in 2014.
Yang P; Chen Y; Jiang S; Shen P; Lu X; Xiao Y
Antimicrob Resist Infect Control; 2018; 7():137. PubMed ID: 30479750
[TBL] [Abstract][Full Text] [Related]
3. Trends and correlation between antibacterial consumption and carbapenem resistance in gram-negative bacteria in a tertiary hospital in China from 2012 to 2019.
Liang C; Zhang X; Zhou L; Meng G; Zhong L; Peng P
BMC Infect Dis; 2021 May; 21(1):444. PubMed ID: 34001022
[TBL] [Abstract][Full Text] [Related]
4. Association between the rate of fluoroquinolones-resistant gram-negative bacteria and antibiotic consumption from China based on 145 tertiary hospitals data in 2014.
Yang P; Chen Y; Jiang S; Shen P; Lu X; Xiao Y
BMC Infect Dis; 2020 Apr; 20(1):269. PubMed ID: 32264851
[TBL] [Abstract][Full Text] [Related]
5. [Impact of antimicrobial stewardship program on antimicrobial usage and detection rate of multidrug-resistant gram-negative bacteria].
Xu YL; Hu LM; Xie ZZ; Dong YW; Dong L
Zhonghua Er Ke Za Zhi; 2019 Jul; 57(7):553-558. PubMed ID: 31269557
[No Abstract] [Full Text] [Related]
6. Effects of various antimicrobial stewardship programs on antimicrobial usage and resistance among common gram-negative bacilli causing health care-associated infections: A multicenter comparison.
Lai CC; Shi ZY; Chen YH; Wang FD
J Microbiol Immunol Infect; 2016 Feb; 49(1):74-82. PubMed ID: 26586483
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization and risk factors for carbapenem-resistant Gram-negative bacilli colonization in children: emergence of NDM-producing Acinetobacter baumannii in a newborn intensive care unit in Turkey.
Karaaslan A; Soysal A; Altinkanat Gelmez G; Kepenekli Kadayifci E; Söyletir G; Bakir M
J Hosp Infect; 2016 Jan; 92(1):67-72. PubMed ID: 26601601
[TBL] [Abstract][Full Text] [Related]
8. Carbapenem-resistant Gram-negative pathogens in a German university medical center: Prevalence, clinical implications and the role of novel β-lactam/β-lactamase inhibitor combinations.
Katchanov J; Asar L; Klupp EM; Both A; Rothe C; König C; Rohde H; Kluge S; Maurer FP
PLoS One; 2018; 13(4):e0195757. PubMed ID: 29649276
[TBL] [Abstract][Full Text] [Related]
9. Safety and clinical outcomes of carbapenem de-escalation as part of an antimicrobial stewardship programme in an ESBL-endemic setting.
Lew KY; Ng TM; Tan M; Tan SH; Lew EL; Ling LM; Ang B; Lye D; Teng CB
J Antimicrob Chemother; 2015 Apr; 70(4):1219-25. PubMed ID: 25473028
[TBL] [Abstract][Full Text] [Related]
10. Temporal association between carbapenems usage and antimicrobial resistance in gram-negative bacteria at a tertiary hospital in Nanjing, China.
Hao Y; Chen S; Chang H; Yan X; Zhou W; Cao X; Huang R; Zhang Z; Zhang H; Jia B; Wu W; Xiong Y; Chen Y; Wu C
Diagn Microbiol Infect Dis; 2020 Oct; 98(2):115083. PubMed ID: 32650282
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and outcome of infections with carbapenem-resistant Gram-negative bacteria treated with polymyxin B-based combination therapy.
Crusio R; Rao S; Changawala N; Paul V; Tiu C; van Ginkel J; Chapnick E; Kupfer Y
Scand J Infect Dis; 2014 Jan; 46(1):1-8. PubMed ID: 24206450
[TBL] [Abstract][Full Text] [Related]
12. Bloodstream infections in children caused by carbapenem-resistant versus carbapenem-susceptible gram-negative microorganisms: Risk factors and outcome.
Ozsurekci Y; Aykac K; Cengiz AB; Basaranoglu ST; Sancak B; Karahan S; Kara A; Ceyhan M
Diagn Microbiol Infect Dis; 2017 Apr; 87(4):359-364. PubMed ID: 28089138
[TBL] [Abstract][Full Text] [Related]
13. Carbapenem Consumption and Rate of carbapenemresistant gram-negative bacteria: results from the Sicilian Surveillance System.
Barchitta M; Maugeri A; La Rosa MC; La Mastra C; Murolo G; Basile G; Agodi A
Ann Ig; 2021; 33(3):289-296. PubMed ID: 33300944
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of carbapenem-resistant Gram-negative infections globally.
Brink AJ
Curr Opin Infect Dis; 2019 Dec; 32(6):609-616. PubMed ID: 31567571
[TBL] [Abstract][Full Text] [Related]
15. Differential correlation between rates of antimicrobial drug consumption and prevalence of antimicrobial resistance in a tertiary care hospital in Greece.
Iosifidis E; Antachopoulos C; Tsivitanidou M; Katragkou A; Farmaki E; Tsiakou M; Kyriazi T; Sofianou D; Roilides E
Infect Control Hosp Epidemiol; 2008 Jul; 29(7):615-22. PubMed ID: 18624668
[TBL] [Abstract][Full Text] [Related]
16. Investigation and analysis of carbapenem-resistant gram-negative bacterial infection rates across hospitals in Shandong Province in China.
Liu K; Xu H; Sun J; Liu Y; Li W
Front Public Health; 2022; 10():1014995. PubMed ID: 36420011
[TBL] [Abstract][Full Text] [Related]
17. Influence of antimicrobial consumption on gram-negative bacteria in inpatients receiving antimicrobial resistance therapy from 2008-2013 at a tertiary hospital in Shanghai, China.
Guo W; He Q; Wang Z; Wei M; Yang Z; Du Y; Wu C; He J
Am J Infect Control; 2015 Apr; 43(4):358-64. PubMed ID: 25838134
[TBL] [Abstract][Full Text] [Related]
18. Activity of cefiderocol (S-649266) against carbapenem-resistant Gram-negative bacteria collected from inpatients in Greek hospitals.
Falagas ME; Skalidis T; Vardakas KZ; Legakis NJ;
J Antimicrob Chemother; 2017 Jun; 72(6):1704-1708. PubMed ID: 28369471
[TBL] [Abstract][Full Text] [Related]
19. Carbapenem susceptibilities and non-susceptibility concordance to different carbapenems amongst clinically important Gram-negative bacteria isolated from intensive care units in Taiwan: results from the Surveillance of Multicentre Antimicrobial Resistance in Taiwan (SMART) in 2009.
Jean SS; Hsueh PR; Lee WS; Yu KW; Liao CH; Chang FY; Ko WC; Wu JJ; Chen YH; Chen YS; Liu JW; Lu MC; Liu CY; Lam C; Chen RJ
Int J Antimicrob Agents; 2013 May; 41(5):457-62. PubMed ID: 23507415
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for hospital-acquired pneumonia caused by carbapenem-resistant Gram-negative bacteria in critically ill patients: a multicenter study in Korea.
Kim T; Chong YP; Park SY; Jeon MH; Choo EJ; Chung JW; Lee HK; Moon C; Kim DM; Peck KR; Kim YS
Diagn Microbiol Infect Dis; 2014 Apr; 78(4):457-61. PubMed ID: 24462178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
